Compare any two GLP-1 providers — on one honest scoreboard.

CoreAge Rx v. Eden

Majority ruling: CoreAge Rx prevails, A to A−.

Eden — FDA warning letter, June 2026. Addressed to Eden Health International Inc. dba Eden, and public in FDA’s warning-letter database.

CoreAge Rx v. Sesame Care

Majority ruling: CoreAge Rx prevails, A to B+.

Dissent: Sesame Care leads on Formulary choice (95 to 88).

CoreAge Rx v. ShedRx

Majority ruling: CoreAge Rx prevails, A to B+.

Dissent: ShedRx leads on Formulary choice (90 to 88).

CoreAge Rx v. Ondra Health

Majority ruling: CoreAge Rx prevails, A to B+.

CoreAge Rx v. Sprout Health

Majority ruling: CoreAge Rx prevails, A to B.

Sprout Health — FDA warning letter, September 2025. Addressed to Sprout Health Partners LLC dba Sprout Health, and public in FDA’s warning-letter database.

CoreAge Rx v. Gala Health

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. HealthRX

Majority ruling: CoreAge Rx prevails, A to B.

Dissent: HealthRX leads on Formulary choice (90 to 88).

CoreAge Rx v. RxSpan MD

Majority ruling: CoreAge Rx prevails, A to B.

Dissent: RxSpan MD leads on Formulary choice (90 to 88).

CoreAge Rx v. Vaylen

Majority ruling: CoreAge Rx prevails, A to B+.

Dissent: Vaylen leads on Formulary choice (91 to 88).

CoreAge Rx v. Invigor Medical

Majority ruling: CoreAge Rx prevails, A to B+.

CoreAge Rx v. Enhance MD

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. Telos Rx

Majority ruling: CoreAge Rx prevails, A to B.

Dissent: Telos Rx leads on Formulary choice (92 to 88).

CoreAge Rx v. Effecty

Majority ruling: CoreAge Rx prevails, A to B+.

CoreAge Rx v. Curex

Majority ruling: CoreAge Rx prevails, A to B+.

Curex — FDA warning letter, September 2025. Addressed to Curex, and public in FDA’s warning-letter database.

CoreAge Rx v. Ro

Majority ruling: CoreAge Rx prevails, A to B+.

Dissent: Ro leads on Formulary choice (92 to 88).

CoreAge Rx v. yourEra

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. Strut Health

Majority ruling: CoreAge Rx prevails, A to B.

Dissent: Strut Health leads on Formulary choice (92 to 88).

Strut Health — FDA warning letter, February 2026. Addressed to Strut Health, LLC dba Strut, and public in FDA’s warning-letter database.

CoreAge Rx v. MadeMed

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. Precision Telemed

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. BetterMe Rx

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. AgelessRx

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. Trimi Health

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. Gimme Care

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. NiceRx

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. Hims & Hers

Majority ruling: CoreAge Rx prevails, A to B.

Hims & Hers — FDA warning letter, September 2025. Addressed to Hims & Hers Health, Inc. dba Hims, and public in FDA’s warning-letter database.

CoreAge Rx v. Direct Meds

Majority ruling: CoreAge Rx prevails, A to B−.

Direct Meds — FDA warning letter, September 2025. Addressed to directmeds.com, Inc. dba DirectMeds, and public in FDA’s warning-letter database.

CoreAge Rx v. Alan Meds

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. Henry Meds

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. bmiMD

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. Live Vital

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. REMEVi

Majority ruling: CoreAge Rx prevails, A to B.

CoreAge Rx v. Synergy Rx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Synergy Rx leads on Formulary choice (90 to 88).

CoreAge Rx v. Mochi Health

Majority ruling: CoreAge Rx prevails, A to B−.

CoreAge Rx v. Fella Health

Majority ruling: CoreAge Rx prevails, A to B−.

CoreAge Rx v. Peak Wellness

Majority ruling: CoreAge Rx prevails, A to B−.

CoreAge Rx v. Elara Health and Wellness

Majority ruling: CoreAge Rx prevails, A to B−.

CoreAge Rx v. StackMD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Apex MD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. FitFlow

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: FitFlow leads on Formulary choice (90 to 88).

CoreAge Rx v. Nalena

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Piper

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Ageless

Majority ruling: CoreAge Rx prevails, A to C.

Ageless — FDA warning letter, September 2025. Addressed to Lovely Meds, Inc. dba Lovely Meds, and public in FDA’s warning-letter database.

CoreAge Rx v. Bodybuilding Health+

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Breeze Meds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. He & She MD

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: He & She MD leads on Formulary choice (92 to 88).

CoreAge Rx v. Rylo Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Big Easy Weight Loss

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. CLYR Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: CLYR Health leads on Formulary choice (92 to 88).

CoreAge Rx v. CoraDoc

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. DrBrainRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Independent Wellness

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Rivo Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Semaglutide Online

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Semaglutide Online leads on Formulary choice (90 to 88).

CoreAge Rx v. Tuyo Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Tuyo Health leads on Formulary choice (90 to 88).

Tuyo Health — FDA warning letter, September 2025. Addressed to Tuyo Health, Inc. dba Tuyo Health, and public in FDA’s warning-letter database.

CoreAge Rx v. ZYP Medical

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Care Bare Rx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Care Bare Rx leads on Formulary choice (92 to 88).

CoreAge Rx v. AskRx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: AskRx leads on Formulary choice (90 to 88).

CoreAge Rx v. AZ Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Candor Rx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Curve

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. HealthSource

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Intimate Rose

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Intimate Rose leads on Formulary choice (92 to 88).

Intimate Rose — FDA warning letter, September 2025. Addressed to Intimate Rose, and public in FDA’s warning-letter database.

CoreAge Rx v. Medro

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Medro leads on Formulary choice (90 to 88).

CoreAge Rx v. RestorLife Med

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Zera Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Tryozi

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Fitish

Majority ruling: CoreAge Rx prevails, A to C.

Fitish — FDA warning letter, June 2026. Addressed to FITISH, and public in FDA’s warning-letter database.

CoreAge Rx v. NextMeds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Claya

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Dr. Gillis' Wellness Center

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. GobyMeds

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: GobyMeds leads on Formulary choice (90 to 88).

CoreAge Rx v. Ivologist

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Jyra Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Kongo

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Navio MD

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Navio MD leads on Formulary choice (90 to 88).

CoreAge Rx v. Rebody Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Rebody Health leads on Formulary choice (92 to 88).

CoreAge Rx v. Revel RX

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TeleCareSpot

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Vytora Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Better U Care

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Better U Care leads on Formulary choice (90 to 88).

CoreAge Rx v. BiltRx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: BiltRx leads on Formulary choice (90 to 88).

CoreAge Rx v. Center for Medical Weight Loss

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. FormidableMD

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: FormidableMD leads on Formulary choice (92 to 88).

CoreAge Rx v. Heally

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Heally leads on Formulary choice (90 to 88).

CoreAge Rx v. Hers

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Hers leads on Formulary choice (90 to 88).

Hers — FDA warning letter, September 2025. Addressed to Hims & Hers Health, Inc. dba Hers, and public in FDA’s warning-letter database.

CoreAge Rx v. Medsol RX

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Remote Pharmacy

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. VitaFusions IV

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Welling Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Cora Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. AmberHealth

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Amble

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Corsica Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Corsica Health leads on Formulary choice (90 to 88).

CoreAge Rx v. GOAL.MD

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: GOAL.MD leads on Formulary choice (92 to 88).

CoreAge Rx v. Harper Meds

Majority ruling: CoreAge Rx prevails, A to C.

Harper Meds — FDA warning letter, June 2026. Addressed to Nexus Health Solutions LLC dba Harper Meds, and public in FDA’s warning-letter database.

CoreAge Rx v. Ivy Rx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Kina

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Layla

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Layla leads on Formulary choice (92 to 88).

CoreAge Rx v. Liberty

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Liberty leads on Formulary choice (90 to 88).

CoreAge Rx v. NuDay Rx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: NuDay Rx leads on Formulary choice (92 to 88).

CoreAge Rx v. NuviaRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. PreventiveMD

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: PreventiveMD leads on Formulary choice (90 to 88).

CoreAge Rx v. Revel Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TOM Weight Loss

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TRYM Health

Majority ruling: CoreAge Rx prevails, A to C.

TRYM Health — FDA warning letter, September 2025. Addressed to TRYM Health, Inc. dba TRYM Health, and public in FDA’s warning-letter database.

CoreAge Rx v. VirtualCare2Go

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Zappy Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Zappy Health leads on Formulary choice (90 to 88).

CoreAge Rx v. Pallas Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Revive Meds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Arc-1

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Blis MD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Jently

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. OurView Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. PepHaūs

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. PeptidesRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. PlushCare

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: PlushCare leads on Formulary choice (90 to 88).

CoreAge Rx v. Premium Health

Majority ruling: CoreAge Rx prevails, A to C.

Premium Health — FDA warning letter, February 2026. Addressed to Premium Health Management Inc. dba Premium Health, and public in FDA’s warning-letter database.

CoreAge Rx v. Rejuve Meds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Somira Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. WeightCare

Majority ruling: CoreAge Rx prevails, A to C.

WeightCare — FDA warning letter, February 2026. Addressed to Weightless Medical LLC dba WeightCare, and public in FDA’s warning-letter database.

CoreAge Rx v. YourHealthRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Zeuss

Majority ruling: CoreAge Rx prevails, A to C.

Zeuss — FDA warning letter, February 2026. Addressed to Zeuss LLC dba Zeuss, and public in FDA’s warning-letter database.

CoreAge Rx v. Get Thin MD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. AlyveRx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: AlyveRx leads on Formulary choice (92 to 88).

CoreAge Rx v. Care Clinics

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. DoctorAdam

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Fitness RX

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Fitness RX leads on Formulary choice (92 to 88).

CoreAge Rx v. Go Vida Plena

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Harbor

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Luma Meds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. OnlineSemaglutide.org

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. PlexusDx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Recovery Delivered

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TeleClinic

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TeleHealth Weight Solutions

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Tru2u

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Voxy

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Oak

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. MyDrHank

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. SkinnyRx

Majority ruling: CoreAge Rx prevails, A to C.

SkinnyRx — FDA warning letter, February 2026. Addressed to Lean Rx, Inc. dba SkinnyRx, and public in FDA’s warning-letter database.

CoreAge Rx v. SnagRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. altRX

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: altRX leads on Formulary choice (90 to 88).

altRX — FDA warning letter, June 2026. Addressed to Trinity HealthCare Supply, LLC dba altRx, and public in FDA’s warning-letter database.

CoreAge Rx v. AMP Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: AMP Health leads on Formulary choice (92 to 88).

AMP Health — FDA warning letter, February 2026. Addressed to Dripgym Mobile Parent, LLC dba Amp Health, and public in FDA’s warning-letter database.

CoreAge Rx v. Bionomy Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Coivas

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Dr. Arevitalize

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. ElixaMD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Healthicare

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Healthicare leads on Formulary choice (92 to 88).

CoreAge Rx v. iThriveMD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Joi + Blokes

Majority ruling: CoreAge Rx prevails, A to C.

Joi + Blokes — FDA warning letter, June 2026. Addressed to Joi and Blokes dba Joi + Blokes, and public in FDA’s warning-letter database.

CoreAge Rx v. LeanDose

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Mevo Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Queen RX

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TeleDocs360

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Tell Her Doc

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Transparent Meds

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Transparent Meds leads on Formulary choice (90 to 88).

CoreAge Rx v. Trava Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Wholesome Clinic

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Wholesome Clinic leads on Formulary choice (92 to 88).

CoreAge Rx v. Wellorithm

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Wellorithm leads on Formulary choice (92 to 88).

CoreAge Rx v. MyFastRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. 24hrDOC

Majority ruling: CoreAge Rx prevails, A to C.

24hrDOC — FDA warning letter, February 2026. Addressed to 24HrDoc, Inc. dba 24HrDoc, and public in FDA’s warning-letter database.

CoreAge Rx v. AbundRX

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Alternate Health Club

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Carocare Wellness

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Clinic Secret

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. EverSlim

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. FitRx

Majority ruling: CoreAge Rx prevails, A to C.

FitRx — FDA warning letter, February 2026. Addressed to FitRX, LLC dba FitRx, and public in FDA’s warning-letter database.

CoreAge Rx v. Kin Meds

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Kin Meds leads on Formulary choice (90 to 88).

Kin Meds — FDA warning letter, February 2026. Addressed to Kin Meds, and public in FDA’s warning-letter database.

CoreAge Rx v. LifeRx.md

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Maves

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. MediRX

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: MediRX leads on Formulary choice (90 to 88).

CoreAge Rx v. MedLeanRx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: MedLeanRx leads on Formulary choice (92 to 88).

CoreAge Rx v. NexLife

Majority ruling: CoreAge Rx prevails, A to C.

NexLife — FDA warning letter, June 2026. Addressed to Nexlife Inc. dba Nexlife, and public in FDA’s warning-letter database.

CoreAge Rx v. Nova MD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. NP2GO

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. NuvaHealth

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: NuvaHealth leads on Formulary choice (92 to 88).

CoreAge Rx v. PCOS Sisters

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: PCOS Sisters leads on Formulary choice (92 to 88).

CoreAge Rx v. Somi Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TelePeptide

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. The Aesthetic Concierge

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. WePeptideRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Avono Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Contour Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. DrMedHealth

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: DrMedHealth leads on Formulary choice (90 to 88).

DrMedHealth — FDA warning letter, June 2026. Addressed to Public Health Solution LLC dba DrMedHealth, and public in FDA’s warning-letter database.

CoreAge Rx v. Eloria

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. EOS Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Freya Meds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. GoodRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. HeliMeds

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: HeliMeds leads on Formulary choice (90 to 88).

CoreAge Rx v. Injectco

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Knownwell

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. LevelsRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Livv

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. LumiMeds

Majority ruling: CoreAge Rx prevails, A to C.

LumiMeds — FDA warning letter, September 2025. Addressed to Lumimeds, and public in FDA’s warning-letter database.

CoreAge Rx v. Neo Soma Healthcare

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. NuBloom

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Optimized Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Options Medical Weight Loss

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Options Medical Weight Loss leads on Formulary choice (90 to 88).

CoreAge Rx v. Regenics

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Regenics leads on Formulary choice (90 to 88).

CoreAge Rx v. Rex MD

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Rex MD leads on Formulary choice (90 to 88).

CoreAge Rx v. Signos

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Society of You

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Society of You leads on Formulary choice (92 to 88).

CoreAge Rx v. Velvet Rx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Willow

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Fierce Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Fierce Health leads on Formulary choice (90 to 88).

CoreAge Rx v. Found

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. System Labs

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Belle Health

Majority ruling: CoreAge Rx prevails, A to C.

Belle Health — FDA warning letter, February 2026. Addressed to Belle Health LLC dba Belle, and public in FDA’s warning-letter database.

CoreAge Rx v. ARSYNL Rx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. BloomWell Rx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Blue Sky MD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Emerge Weight Loss

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. LIV by WellNow

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. NativeMed

Majority ruling: CoreAge Rx prevails, A to C.

NativeMed — FDA warning letter, June 2026. Addressed to NativeMed LLC dba NativeMed, and public in FDA’s warning-letter database.

CoreAge Rx v. Obu Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. RedBox Rx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Trinity Meds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Valhalla Vitality

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. VyrarX

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Bodi Envi

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Allara Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Ark Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Ark Health leads on Formulary choice (92 to 88).

CoreAge Rx v. Ascend Vitality

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Bioverse

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Bioverse leads on Formulary choice (90 to 88).

Bioverse — FDA warning letter, September 2025. Addressed to Bioverse, Inc. dba Bioverse, and public in FDA’s warning-letter database.

CoreAge Rx v. Citizen Meds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. ElitePhysiqMD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. eMI Aesthetics

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Form Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Form Health leads on Formulary choice (90 to 88).

CoreAge Rx v. Lavender Sky Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Lean Rx

Majority ruling: CoreAge Rx prevails, A to C.

Lean Rx — FDA warning letter, February 2026. Addressed to Lean Rx, Inc. dba SkinnyRx, and public in FDA’s warning-letter database.

CoreAge Rx v. Lemonaid Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Levers Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Lumen Meds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Measured

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Measured leads on Formulary choice (90 to 88).

Measured — FDA warning letter, February 2026. Addressed to Better Health Labs, Inc. dba Measured, and public in FDA’s warning-letter database.

CoreAge Rx v. Novi

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. NovoCare Pharmacy

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. NowPatient

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: NowPatient leads on Formulary choice (92 to 88).

CoreAge Rx v. PrideRx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: PrideRx leads on Formulary choice (92 to 88).

CoreAge Rx v. YOURx Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Alloy

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Alloy leads on Formulary choice (92 to 88).

CoreAge Rx v. BioGlow Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: BioGlow Health leads on Formulary choice (90 to 88).

CoreAge Rx v. Coby Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Cost Plus Drugs

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Elevate Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Elevate Health leads on Formulary choice (90 to 88).

CoreAge Rx v. Elevated Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Elevated Health leads on Formulary choice (92 to 88).

CoreAge Rx v. Gaya Wellness

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. InstaRX

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. June Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Lyfe Rx

Majority ruling: CoreAge Rx prevails, A to C.

Lyfe Rx — FDA warning letter, September 2025. Addressed to Lyfe Rx, and public in FDA’s warning-letter database.

CoreAge Rx v. Mint Medical Clinic

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. OrderlyMeds

Majority ruling: CoreAge Rx prevails, A to C.

OrderlyMeds — FDA warning letter, June 2026. Addressed to OrderlyMeds LLC dba OrderlyMeds, and public in FDA’s warning-letter database.

CoreAge Rx v. Vitalex Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Whoosh Wellness

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Whoosh Wellness leads on Formulary choice (90 to 88).

CoreAge Rx v. Tyde Wellness

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Vitara RX

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. FMmeds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Alegro Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. AquaVita NextGen

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. boostAGErx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: boostAGErx leads on Formulary choice (90 to 88).

CoreAge Rx v. Calibrate Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Elara MD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Heros Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Luma Health Co

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. OnlyRx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: OnlyRx leads on Formulary choice (92 to 88).

CoreAge Rx v. Onyx Weight Loss

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. QuickMD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. ReadyRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. RxPros

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Ryze Rx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Southern Vitality Weight Loss

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Super Healthy Rx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Tonik Wellness

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. tru Weight Loss

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Vital Edge

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Vital Edge leads on Formulary choice (92 to 88).

CoreAge Rx v. Youth & Soul

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Aquivia Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Aquivia Health leads on Formulary choice (90 to 88).

CoreAge Rx v. Lttl

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. MyStart Health

Majority ruling: CoreAge Rx prevails, A to C.

MyStart Health — FDA warning letter, September 2025. Addressed to Matthew Stern, CEO MyStart Health LLC., and public in FDA’s warning-letter database.

CoreAge Rx v. Fresh Day Meds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Trillium Meds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. EdgeRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. 10rx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. AVARA Rx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: AVARA Rx leads on Formulary choice (90 to 88).

CoreAge Rx v. GetRelief Rx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: GetRelief Rx leads on Formulary choice (92 to 88).

CoreAge Rx v. HelloWellness

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Invyncible

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Ivim Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. LevelUp Rx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. LunaRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Mojoon

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Primary Clinic

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. RxSaludable

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: RxSaludable leads on Formulary choice (90 to 88).

CoreAge Rx v. Wisp

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Wisp leads on Formulary choice (92 to 88).

CoreAge Rx v. HumeCare+

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Mint Med

Majority ruling: CoreAge Rx prevails, A to C.

Mint Med — FDA warning letter, June 2026. Addressed to Glow Medispa, LLC dba Mint Med, and public in FDA’s warning-letter database.

CoreAge Rx v. Amazon One Medical

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Factor Health MD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Genesis Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Genesis Health leads on Formulary choice (90 to 88).

Genesis Health — FDA warning letter, February 2026. Addressed to Genesis Health International Inc. dba Genesis, and public in FDA’s warning-letter database.

CoreAge Rx v. Good Girl Rx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Good Girl Rx leads on Formulary choice (92 to 88).

Good Girl Rx — FDA warning letter, February 2026. Addressed to Good Girl LLC dba GoodGirlRX, and public in FDA’s warning-letter database.

CoreAge Rx v. HealthOn

Majority ruling: CoreAge Rx prevails, A to C.

HealthOn — FDA warning letter, September 2025. Addressed to Healthon Inc. dba Healthon, and public in FDA’s warning-letter database.

CoreAge Rx v. Heva Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Livea

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Luci

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. LVNG RX

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Nucore Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Prime Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Rewinding RX

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. ShapeIn Rx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Silhouette MD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TeleHealth Med

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Spry

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Superior Remedies

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Luvo Health

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Luvo Health leads on Formulary choice (90 to 88).

CoreAge Rx v. BeyondMD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Eve

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Eve leads on Formulary choice (92 to 88).

CoreAge Rx v. Fitstry

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. FormBlends

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: FormBlends leads on Formulary choice (90 to 88).

CoreAge Rx v. Harmony Wellness Clinic

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. LaSara Medical Group

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Levity

Majority ruling: CoreAge Rx prevails, A to C.

Levity — FDA warning letter, February 2026. Addressed to Levity Inc. dba Levity, and public in FDA’s warning-letter database.

CoreAge Rx v. Lumora

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. MANÜ Telehealth

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Nurx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Nurx leads on Formulary choice (90 to 88).

CoreAge Rx v. Open Water Rx

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Open Water Rx leads on Formulary choice (90 to 88).

CoreAge Rx v. Ozari Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Pomegranate Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. PrescribedRX

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: PrescribedRX leads on Formulary choice (90 to 88).

CoreAge Rx v. Remedy Meds

Majority ruling: CoreAge Rx prevails, A to C.

Remedy Meds — FDA warning letter, September 2025. Addressed to Remedy Meds, and public in FDA’s warning-letter database.

CoreAge Rx v. Remi Meds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Vyora Wellness

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Woodwork

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TrueMe

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Cielo

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Bliv

Majority ruling: CoreAge Rx prevails, A to C.

Bliv — FDA warning letter, February 2026. Addressed to Bliv Wellness LLC dba Bliv, and public in FDA’s warning-letter database.

CoreAge Rx v. Bon Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. ClickSlim

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Concierge MD LA

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: Concierge MD LA leads on Formulary choice (90 to 88).

CoreAge Rx v. CVS MinuteClinic

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Fidelity Medical Clinic

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Framework

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. LifeMD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Potere Health MD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Roboclinic

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Vita Bella

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. PauseRX

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Nirwana Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. NewSelf

Majority ruling: CoreAge Rx prevails, A to C.

NewSelf — FDA warning letter, February 2026. Addressed to NewSelf Limited dba NewSelf, and public in FDA’s warning-letter database.

CoreAge Rx v. 9amHealth

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Call-On-Doc

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Joey Med

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Marek Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Next Vial

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Roen Rx

Majority ruling: CoreAge Rx prevails, A to C.

Roen Rx — FDA warning letter, June 2026. Addressed to Roen Health, Inc. dba RoenRx, and public in FDA’s warning-letter database.

CoreAge Rx v. SkyRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TeleZen MD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TRT Nation

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. NuuVim

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: NuuVim leads on Formulary choice (92 to 88).

CoreAge Rx v. Actin

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Dollar Dad Club

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. FuturHealth

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. LillyDirect Foundayo

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Medi-Weightloss

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Push Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. T2D.com

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Walgreens Weight Management

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Sunlight

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Aspen

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Embody

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Nolu

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Boston Medical Group

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. DreamHug Medical

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Empower Pharmacy

Majority ruling: CoreAge Rx prevails, A to C.

Empower Pharmacy — FDA warning letter, April 2025. Addressed to Empower Clinic Services, LLC dba Empower Pharmacy, and public in FDA’s warning-letter database.

CoreAge Rx v. Human+

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. LifespanningRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Metabolyz

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Rixa Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. VivioMD

Majority ruling: CoreAge Rx prevails, A to C.

VivioMD — FDA warning letter, June 2026. Addressed to VivioMD Group LLC dba VivioMD, and public in FDA’s warning-letter database.

CoreAge Rx v. WeightWatchers Clinic

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. KERNX Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. 1st Optimal

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Always Wellness and Recovery

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. AVArx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Klinic

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Strive Pharmacy

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Fifty 410

Majority ruling: CoreAge Rx prevails, A to C.

Fifty 410 — FDA warning letter, February 2026. Addressed to Aspen Aesthetics dba Fifty 410, and public in FDA’s warning-letter database.

CoreAge Rx v. Garcia Weight Loss

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Midi Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Noom Med

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Royal Medical Center

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. RxPepsDirect

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Shapely

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Teleios Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TideMedix

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Nouri

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Peter MD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. WellMedr

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. FORM (by GBY)

Majority ruling: CoreAge Rx prevails, A to C.

Dissent: FORM (by GBY) leads on Formulary choice (90 to 88).

CoreAge Rx v. BodyLogicMD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. CaliberRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Chronos Body Health & Wellness

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Enara Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Gatlan

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Hello Alpha

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Hormonally Balanced

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Mirabel Meds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TD Tele-Doc Weight Loss

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. WeightRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Zealthy

Majority ruling: CoreAge Rx prevails, A to C.

Zealthy — FDA warning letter, September 2025. Addressed to FitRX, LLC dba Zealthy, and public in FDA’s warning-letter database.

CoreAge Rx v. Aspire Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Eclipse Medical Wellness

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. ElleS

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Evernow

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. JRNYS

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Maven Clinic

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. MDLive

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Meto

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Nuform Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. The Virtual NP

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Virta Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Mixx Health & Wellness

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Ascend Medical

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Aurelius Health Group

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Balanced Hormone Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Defy Medical

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. EmbraceRX

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. EverFit Medical

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. FeelGood

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Loop Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. MultiMedRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Nava Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Peptivo

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Vea Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Ambiante Health & Wellness

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Cabana

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. EllieMD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. eMed

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Evolve Telemed

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Florida Weight Loss MD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. FlyteHealth

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Fridays

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. G-Plans

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Good Life Meds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Ilant Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. JM Integrated Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. JumpstartMD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Klarity Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. MDExam

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. MEDVidi

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Nu Image Medical

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Nucific

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Omada Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Rivas Medical Weight Loss

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Shape Vantage

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Steady State Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Stealth Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Teladoc Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TeleSlim Clinic

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Oxford's Medical Weight Loss

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. This Gen Wellness

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Transcarent

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Vida Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. VigorMeds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Better MedSpa

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Brello Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. DadVantage Men's Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Genesis Lifestyle Medicine

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Immortals

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Iron Med RX

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. myRocky

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Näky

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Omzo

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Ravia Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. RegenCen

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Reset Solutions

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Risen Labs

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. RxION Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TeleFirst Med

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TRT Kingdom

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. UR Meds

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Wellspring Longevity Clinic

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Sumbare Wellness

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Blue Haven RX

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Kova

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. MD Trim Clinic

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Medivive

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Modern Age

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. MyDietDoc

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Omnia TeleHealth

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Refills

Majority ruling: CoreAge Rx prevails, A to C.

Refills — FDA warning letter, February 2026. Addressed to Refills Health, LLC dba Refills Health, and public in FDA’s warning-letter database.

CoreAge Rx v. SynergenX Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. TeleWellnessMD

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Thriving Again

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. WeightlessRx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Beluga Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Green Cap Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. HealthHub

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Ways2Well

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. ZipHealth

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Medical Health Institute

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Basal Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. California Trim Clinic

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. PRIMO Health Partners

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Trimrose

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Vital Harmony Rx

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. AM Rx

Majority ruling: CoreAge Rx prevails, A to C.

AM Rx — FDA warning letter, June 2026. Addressed to FitRX, LLC dba AM RX, and public in FDA’s warning-letter database.

CoreAge Rx v. Tablet Health

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Unique Physique

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. Bodyshop Wellness

Majority ruling: CoreAge Rx prevails, A to C.

CoreAge Rx v. OlleveCare

Majority ruling: CoreAge Rx prevails, A to C.